FA-PEG3-DOTA CAS:1255610-94-6 is a type of small molecule drug that is composed of several functional groups. The FA group is short for folic acid, which is a type of vitamin that plays an important role in many biological processes, including cell division and DNA synthesis. The PEG3 group is a polyethylene glycol spacer that is used to improve the solubility and stability of the drug in solution, allowing it to be more easily administered to patients. The DOTA group is a chelating agent that is used to bind to certain metal ions, such as gadolinium or yttrium, for use in medical imaging and cancer therapy.
The combination of these functional groups in FA-PEG3-DOTA is designed to create a drug that can be used for targeted drug delivery and imaging in cancer treatment. Folic acid is known to bind to a specific receptor that is overexpressed in many types of cancer cells, allowing FA-PEG3-DOTA to selectively target and bind to these cells. The PEG3 spacer improves the solubility and stability of the drug, while the DOTA group can be used to bind to certain metal ions for use in imaging or therapy.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.
